These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1663728)

  • 21. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
    Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    Intervirology; 1997; 40(5-6):295-303. PubMed ID: 9675635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitrypanosomal activity of phosphonylmethoxyalkylpurines.
    Kaminsky R; Zweygarth E; De Clercq E
    J Parasitol; 1994 Dec; 80(6):1026-30. PubMed ID: 7799144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents.
    De Clercq E
    Drugs Exp Clin Res; 1990; 16(7):319-26. PubMed ID: 1965499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS research. New drug shows promise in monkeys.
    Cohen J
    Science; 1995 Nov; 270(5239):1121-2. PubMed ID: 7502035
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel selective broad-spectrum anti-DNA virus agent.
    De Clercq E; Holý A; Rosenberg I; Sakuma T; Balzarini J; Maudgal PC
    Nature; 1986 Oct 2-8; 323(6087):464-7. PubMed ID: 3762696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
    Naesens L; Balzarini J; De Clercq E
    Postepy Biochem; 1995; 41(5 Suppl):347-51. PubMed ID: 8797236
    [No Abstract]   [Full Text] [Related]  

  • 29. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    Snoeck R; Andrei G; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
    Quenelle DC; Collins DJ; Herrod BP; Keith KA; Trahan J; Beadle JR; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3940-7. PubMed ID: 17846137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis.
    Yokota T; Mochizuki S; Konno K; Mori S; Shigeta S; De Clercq E
    Nucleic Acids Symp Ser; 1990; (22):17-8. PubMed ID: 2101900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication.
    Lin JC; DeClercq E; Pagano JS
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1431-3. PubMed ID: 2823699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems.
    Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E
    Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase.
    Cerný J; Votruba I; Vonka V; Rosenberg I; Otmar M; Holý A
    Antiviral Res; 1990 May; 13(5):253-64. PubMed ID: 2168691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil on seal herpesvirus (phocid herpesvirus 1) infection in vitro.
    Osterhaus AD; Groen J; De Clercq E
    Antiviral Res; 1987 May; 7(4):221-6. PubMed ID: 3619434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.